dc.contributor.author | Cover, Jane K. | |
dc.contributor.author | Drake, Jennifer Kidwell | |
dc.contributor.author | Kyamwanga, Imelda T. | |
dc.contributor.author | Turyakira, Eleanor | |
dc.contributor.author | Dargan, Tanya | |
dc.contributor.author | Kumakech, Edward | |
dc.contributor.author | Harner-Jay, Claudia | |
dc.date.accessioned | 2022-09-16T12:47:56Z | |
dc.date.available | 2022-09-16T12:47:56Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Cover, J. K., Drake, J. K., Kyamwanga, I. T., Turyakira, E., Dargan, T., Kumakech, E., & Harner-Jay, C. (2013). Consumer perspectives on a pericoital contraceptive pill in India and Uganda. International perspectives on sexual and reproductive health, 195-204. | en_US |
dc.identifier.uri | http://ir.must.ac.ug/xmlui/handle/123456789/2477 | |
dc.description.abstract | Context: Studies suggest that women in some countries have adopted emergency contraceptive pills as a routine method of family planning. This practice indicates there may be latent demand for a pericoital contraceptive pill taken only when a woman has sexual intercourse, and labeled and marketed for use as a regular contraceptive method.
Methods: To understand the appeal and potential market for a pericoital contraceptive pill, 39 focus groups and 23 in-depth interviews were conducted with women and men in Lucknow, Uttar Pradesh, India, and Kampala, Uganda. A total of 281 individuals participated in this qualitative study.
Results: In general, women embraced the idea of a female-controlled method that would be easier than taking a daily oral contraceptive pill and that could be taken either before or after sexual intercourse; in Uganda, especially, women approved of the fact that the method could be taken without a partner’s knowledge. Although we do not yet know the extent of side effects for this method, women expressed some concerns about the level and nature of potential side effects. Conclusions: The results suggest that a pericoital contraceptive pill would be well-received by consumers in both country settings. If its efficacy and side effects are acceptable, a pericoital contraceptive pill could fill a gap for female-controlled, discreet, coitus-related contraception, particularly among women who do not have sex very frequently | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | International perspectives on sexual and reproductive health | en_US |
dc.subject | Consumer Perspectives | en_US |
dc.subject | Contraceptives | en_US |
dc.subject | Pill | en_US |
dc.subject | Uganda | en_US |
dc.title | Consumer Perspectives on a Pericoital Contraceptive Pill In India and Uganda | en_US |
dc.type | Article | en_US |